Gevokizumab: all 21 studies that test it
Page 1 of 1. Open to participants first (0), then studies with results posted, then the rest; newest registration first within each.
- A Single Arm Phase II Study to Evaluate Treatment With Gevokizumab in Patients With Stage II/III Colon Cancer Who Are ctDNA-positive After Curative Surgery and Adjuvant ChemotherapyWithdrawnNCT05178576Phase 2
- Long-term Safety of Gevokizumab in the Treatment of Patients With Chronic Non-infectious Uveitis (EYEGUARD-X)TerminatedNCT02375685Phase 3
- An Efficacy and Safety Study of Gevokizumab in Treating Active Ulcers of Pyoderma GangrenosumTerminatedNCT02326740Phase 3
- A 2-Year, Open-Label, Safety Extension Study of Gevokizumab in Subjects With Pyoderma GangrenosumTerminatedNCT02318914Phase 3
- An Efficacy and Safety Study of Gevokizumab in Treating Active Ulcers of Pyoderma GangrenosumTerminatedNCT02315417Phase 3
- Open-label Safety Extension Study of Gevokizumab in Erosive Osteoarthritis of the HandCompletedNCT02293564Not applicable
- Efficacy and Safety Study of Gevokizumab to Treat Behcet's Disease UveitisTerminatedNCT02258867Phase 3
- Efficacy of Gevokizumab in the Treatment of Patients With Behçet's Disease Uveitis (EYEGUARD™-B)TerminatedNCT01965145Phase 3
- The Effects of Gevokizumab in Corticosteroid-resistant Subjects With Autoimmune Inner Ear DiseaseCompletedNCT01950312Phase 2
- Proof of Concept Study of Gevokizumab in the Treatment of Pyoderma GangrenosumCompletedNCT01882504Phase 2
- Safety and Biologic Activity Study of Gevokizumab to Treat Erosive Osteoarthritis of the HandCompletedNCT01882491Phase 2
- Effects of XOMA 052 on Insulin Production in Type 1 DiabetesCompletedNCT01788033Phase 2
- Safety and Biologic Activity Study of Gevokizumab to Treat Erosive Osteoarthritis of the HandCompletedNCT01683396Phase 2
- Efficacy and Safety Study of Gevokizumab to Treat Moderate to Severe Acne VulgarisCompletedNCT01498874Phase 2
- A Pilot Study of XOMA 052 in Familial Cold Autoinflammatory Syndrome / Muckle-Wells Syndrome and Behcet's DiseaseWithdrawnNCT01211977Phase 1/2
- Study of the Safety and Biologic Activity of XOMA 052 in Subjects With Type 2 Diabetes MellitusCompletedNCT01144975Phase 2
- Safety and Efficacy of XOMA 052 in Subjects With Type 2 Diabetes Mellitus on Stable Metformin MonotherapyCompletedNCT01066715Phase 2
- Study of the Effects of XOMA 052 on Insulin Production in Subjects With Well Controlled Type 1 DiabetesCompletedNCT00998699Phase 2
- Safety and Pharmacokinetics Study of XOMA 052 in Subjects With Active, Stable, Moderate to Severe Rheumatoid ArthritisSuspendedNCT00777816Phase 2
- Single-dose, Dose-escalation Study of Safety, PK, and Preliminary Efficacy of XOMA 052 in Type 2 Diabetes MellitusCompletedNCT00541983Phase 1
- Safety and Pharmacokinetics Study of XOMA 052 in Subjects With Type 2 Diabetes MellitusCompletedNCT00513214Phase 1/2